Related Experiment Video
Updated: Oct 30, 2025

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
Optical tissue clearing and machine learning can precisely characterize extravasation and blood vessel architecture
Serhii Kostrikov1, Kasper B Johnsen1, Thomas H Braunstein2
1Section for Biotherapeutic Engineering and Drug Targeting, Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.
Abstract:
Precise methods for quantifying drug accumulation in brain tissue are currently very limited, challenging the development of new therapeutics for brain disorders. Transcardial perfusion is instrumental for removing the intravascular fraction of an injected compound, thereby allowing for ex vivo assessment of extravasation into the brain. However, pathological remodeling of tissue microenvironment can affect the efficiency of transcardial perfusion, which has been largely overlooked. We show that, in contrast to healthy vasculature, transcardial perfusion cannot remove an injected compound from the tumor vasculature to a sufficient extent leading to considerable overestimation of compound extravasation. We demonstrate that 3D deep imaging of optically cleared tumor samples overcomes this limitation. We developed two machine learning-based semi-automated image analysis workflows, which provide detailed quantitative characterization of compound extravasation patterns as well as tumor angioarchitecture in large three-dimensional datasets from optically cleared samples. This methodology provides a precise and comprehensive analysis of extravasation in brain tumors and allows for correlation of extravasation patterns with specific features of the heterogeneous brain tumor vasculature.
Insights
Transcardial perfusion overestimates drug extravasation in brain tumors due to incomplete removal from tumor vasculature. New 3D deep imaging and machine learning methods precisely quantify drug extravasation and tumor angioarchitecture.
Area of Science:
- Neuroscience
- Pharmacology
- Biomedical Imaging
Background:
- Accurate quantification of drug accumulation in brain tissue is crucial for developing therapeutics for brain disorders.
- Transcardial perfusion is a standard method to assess drug extravasation into the brain by removing intravascular drug fractions.
- The efficiency of transcardial perfusion can be compromised by pathological changes in the tumor microenvironment, a factor often overlooked.
Purpose of the Study:
- To investigate the impact of tumor vasculature on transcardial perfusion efficiency.
- To develop advanced imaging and analysis techniques for precise quantification of drug extravasation in brain tumors.
- To characterize brain tumor angioarchitecture and its correlation with drug extravasation patterns.
Main Methods:
- Utilized 3D deep imaging of optically cleared tumor samples to overcome limitations of traditional perfusion methods.
- Developed two machine learning-based semi-automated image analysis workflows.
- Quantified compound extravasation patterns and tumor angioarchitecture in large 3D datasets.
Main Results:
- Demonstrated that transcardial perfusion is insufficient for removing injected compounds from tumor vasculature, leading to significant overestimation of extravasation compared to healthy vasculature.
- Successfully characterized compound extravasation patterns and tumor angioarchitecture using the developed 3D imaging and machine learning workflows.
- Established a methodology for precise and comprehensive analysis of extravasation in brain tumors.
Conclusions:
- Transcardial perfusion is unreliable for quantifying drug extravasation in brain tumors due to incomplete intravascular washout.
- 3D deep imaging combined with machine learning offers a precise method for analyzing drug extravasation and tumor vasculature.
- This approach enables detailed correlation between extravasation patterns and the heterogeneous features of brain tumor vasculature, advancing therapeutic development.
More Related Videos
07:26Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research
Published on: September 15, 2023
09:09Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion
Published on: April 12, 2020